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Abstract
Background: Development of type 2 diabetes mellitus (T2DM) is characterized by aberrant
insulin secretory patterns, where elevated insulin levels at non-stimulatory basal conditions and
reduced hormonal levels at stimulatory conditions are major components. To delineate
mechanisms responsible for these alterations we cultured INS-1E cells for 48 hours at 20 mM
glucose in absence or presence of 0.5 mM palmitate, when stimulatory secretion of insulin was
reduced or basal secretion was elevated, respectively.
Results: After culture, cells were protein profiled by SELDI-TOF-MS and 2D-PAGE. Differentially
expressed proteins were discovered and identified by peptide mass fingerprinting. Complimentary
protein profiles were obtained by the two approaches with SELDI-TOF-MS being more efficient in
separating proteins in the low molecular range and 2D-PAGE in the high molecular range. Identified
proteins included alpha glucosidase, calmodulin, gars, glucose-6-phosphate dehydrogenase,
heterogenous nuclear ribonucleoprotein A3, lon peptidase, nicotineamide adenine dinucleotide
hydrogen (NADH) dehydrogenase, phosphoglycerate kinase, proteasome p45, rab2, pyruvate
kinase and t-complex protein. The observed glucose-induced differential protein expression
pattern indicates enhanced glucose metabolism, defense against reactive oxygen species, enhanced
protein translation, folding and degradation and decreased insulin granular formation and
trafficking. Palmitate-induced changes could be related to altered exocytosis.
Conclusion: The identified altered proteins indicate mechanism important for altered β-cell
function in T2DM.
Background
Reduced insulin secretory capacity and loss of mass of the
pancreatic β-cells are hallmarks in the development of
type 2 diabetes mellitus (T2DM) [1,2]. The aberrant insu-
lin secretory characteristics have been linked to exposure
of the cells to prolonged periods of elevated glucose and
fatty acid levels [3]. The secretory alterations depend on
what fatty acid is present during exposure and include
enhanced secretion at basal glucose concentrations and/
or lowered insulin levels at elevated glucose concentra-
tions [3,4]. These alterations lead to reduced or even abol-
ished glucose-stimulated insulin secretion (GSIS). In
addition, β-cell mass is reduced by the combined eleva-
tion of glucose and fatty acids [5]. The fatty acid palmitate
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has especially negative effects on both β-cell function and
mass via different mechanisms [4,6-10]. Despite these
efforts to define causes responsible for the altered insulin
secretory pattern observed after exposure to elevated levels
of glucose and palmitate, underlying mechanisms remain
to a large extent undefined. In an attempt to further
understand how elevated levels of the two nutrients cause
the secretory alterations and taking the polygenicity of
obesity-induced type 2 diabetes mellitus into account
[11], insulin-producing INS-1E cells were cultured in the
presence of elevated levels of glucose and palmitate and
protein profiled. In addition, INS-1E cells over-expressing
the fatty acid transporter carnitine palmityoltransferase 1
(CPT1) were also protein profiled. The latter approach
was inspired from recent results, where improvement of
insulin release in INS-1E cells exposed to palmitate was
achieved by redirecting the fatty acid from esterification to
oxidation by over-expressing CPT1 in INS-1E cells [12].
In previous work we have employed SELDI-TOF-MS and
2D-PAGE for β-cell protein profiling [13,14]. Given the
advantages but also limitations of the approaches [15], in
the present study we employed both strategies to deter-
mine protein patterns of insulin-producing cells with
aberrant secretory pattern as a result of exposing the cells
to either elevated levels of glucose or palmitate. The study
allowed methodological comparisons and identification
of β-cell proteins differentially expressed by palmitate or
glucose, which may represent mechanisms by which the
nutrients negatively affect GSIS.
Results
Glucose-stimulated insulin secretion and insulin content of 
INS-1E cells
INS-1E cells were cultured for 48 hours in the presence of
5.5 or 20 mM glucose in the absence or presence of palmi-
tate. After culture, GSIS was determined by measuring
insulin release in response to 3 (basal) or 20 (stimulatory)
mM glucose during 30 min (Fig 1A). In cells cultured in
the presence of 5.5 mM glucose alone, insulin release dur-
ing the 30-minute period increased more than 10-fold
when insulin released at 3 mM glucose was compared
with that released at 20 mM. When the culture glucose
concentration was raised to 20 mM glucose, insulin
release during the 30-minute period in the presence of the
stimulatory glucose concentration (20 mM) was reduced
to such an extent that it was not different from that
released from cells acutely exposed to the basal glucose
concentration (3 mM). When palmitate was included dur-
ing culture of cells exposed to 5.5 or 20 mM glucose, insu-
lin release during the subsequent 30-minute period in
response to 3 mM glucose was enhanced. In addition,
insulin released during the 30-minute period in response
to 20 mM glucose was reduced. As a consequence the dif-
ference between basal and stimulatory insulin release was
decreased especially in cells cultured in the presence of 20
mM glucose and palmitate.
Insulin release from cells cultured in the presence of 5.5 or
20 mM glucose and palmitate was also measured during
the 30-minute period following the culture in the contin-
ued presence of the fatty acid. Under these conditions
insulin secretion in response to 20 mM glucose during the
Insulin secretion from gluco- and lipotoxic INS-1E cells Figure 1
Insulin secretion from gluco- and lipotoxic INS-1E 
cells. Insulin release (A) and content (B) from INS-1E cells 
cultured at 5.5 or 20 mM glucose (Glu) in the absence or 
presence of 0.5 mM palmitate (PA) for 48 hours. Insulin 
secretion was measured by acutely stimulating the cells with 
3 mM (white bars), 20 mM glucose (grey bars), 3 mM glucose 
and palmitate (white hatched bars) or 20 mM glucose and 
palmitate (grey hatched bars) for 30 minutes after culture at 
the indicated culture conditions. Insulin release and content 
were normalized to total protein. Results are means ± SEM 
for four to six independent experiments. *p < 0.05 compared 
to basal insulin release, #p < 0.05 compared to stimulatory 
insulin release from cells cultured at 5.5 mM glucose, §p < 
0.05 compared to basal insulin release from cells cultured at 
5.5 or 20 mM glucose, †p < 0.05 denotes effect of 20 mM 
glucose.Proteome Science 2009, 7:24 http://www.proteomesci.com/content/7/1/24
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30-minute period was similar to that observed from con-
trol cells cultured in the presence of 5.5 mM glucose
alone. Despite the augmented stimulatory insulin secre-
tion, GSIS was still impaired since basal insulin release
during the 30-minute period was still elevated. In view of
these changes in insulin release we conclude that whereas
impaired GSIS from INS-1E cultured in the presence of
elevated levels of glucose alone was the result of reduced
stimulatory insulin release, impaired GSIS in the presence
of palmitate during the culture period resulted in
enhanced basal insulin release.
Insulin content of INS-1E cells cultured for 48 hours was
measured. Whereas inclusion of palmitate did not affect
insulin content of INS-1E cells, increasing the culture glu-
cose concentration from 5.5 to 20 mM reduced insulin
content (Fig 1B).
Elevation of basal insulin release: differential INS-1E 
protein expression induced by palmitate
To elucidate mechanisms by which prolonged exposure to
palmitate increase basal insulin release, INS-1E cells were
cultured in the absence or presence of palmitate at 20 mM
glucose. After culture, protein profiles were generated by
SELDI-TOF-MS and 2D-PAGE. Altogether 28 palmitate-
regulated proteins were discovered, 11 by the former and
17 by the latter approach (Table 1). Three proteins, which
were down-regulated by palmitate and had tentative
masses of 16.8, 17.0 and 17.2 kDa, were located in a part
of the mass spectrum with less frequent other peaks (Fig
2A). The proteins were purified and identified as calmod-
ulin (Table 2 and 3).
We previously observed that basal insulin release was low-
ered in INS-1E cells cultured in the presence of 20 mM
glucose and palmitate when CPT1 was over-expressed in a
regulated manner [12]. To delineate mechanisms by
which elevated CPT1-levels corrected basal insulin
release, INS-1E cells cultured in the presence of 20 mM
glucose and palmitate and expressing different levels of
CPT1 were protein profiled using either protein array fol-
lowed by SELDI-TOF-MS or 2D-PAGE. When searching
for INS-1E proteins with expression levels correlating with
CPT1 expression levels, a 7.14 kDa protein was found (Fig
3). This protein was induced in INS-1E cells cultured in
the presence of 20 mM glucose and palmitate compared
to cells cultured in the absence of palmitate. The 7.14 kDa
protein was decreased to levels observed in control cells,
when CPT1 was over-expressed. Since calmodulin was
down-regulated in INS-1E cells exposed to palmitate (Fig
2A), we also measured amounts of calmodulin in INS-1E
cells over-expressing CPT1. The peaks appearing at masses
16.8, 17.0 and 17.2 kDa were not altered in INS-1E with
increased CPT1 levels, however (data not shown).
Attenuation of stimulatory insulin release: differential INS-
1E protein expression induced by high glucose
To elucidate mechanisms by which prolonged exposure to
elevated glucose levels decrease stimulatory insulin
release, INS-1E cells were cultured at 5.5 or 20 mM glu-
cose. After culture, protein profiles were generated by
SELDI-TOF-MS and 2D-PAGE. When stringent peak and
spot detection criteria were applied, 34 differentially
expressed proteins remained that were glucose-regulated.
Whereas five proteins were discovered by the former
approach, 29 proteins were detected by the latter
approach (Table 4). Eleven proteins were identified as
alpha glucosidase, gars, glucose-6-phosphate dehydroge-
nase, heterogenous nuclear ribonucleoprotein A3, lon
peptidase, nicotineamide adenine dinucleotide hydrogen
(NADH) dehydrogenase, phosphoglycerate kinase, pro-
teasome p45, rab2, pyruvate kinase and t-complex protein
(Table 2 and 3). All identified proteins were up-regulated
by elevated glucose levels (Table 4) and their positions in
the 2D-PAGE map were marked by their gene names (Fig
2B).
Discussion
In the present study mechanism of aberrant GSIS were
delineated by protein profiling of insulin-producing cells
cultured at elevated levels of glucose and palmitate using
SELDI-TOF-MS and 2D-PAGE.
INS-1E cells cultured at control condition of 5.5 mM glu-
cose responded to stimulatory glucose concentration,
GSIS, with approximately 10-fold enhanced insulin secre-
tion over a 30-min period compared to basal insulin
secretion, which is comparable to the secretory response
of human islets [16,17]. However, in individuals with
T2DM, GSIS is severely reduced or even absent [2,17,18].
Such alterations in the dynamic range of insulin levels are
the result of lowered insulin release at stimulatory glucose
concentrations combined or not with elevated insulin
secretion at non-stimulatory glucose levels, the basal insu-
lin secretion. Whereas absent initial rise of insulin release
is a hallmark of T2DM [2,18,19], elevated basal insulin
release is characteristic of T2DM individuals with insulin
resistance [20]. The latter individuals display both hyper-
glycemia and hyperlipidemia, which made us investigate
how elevated levels of glucose and fatty acid palmitate
affected the insulin-producing cell. Palmitate was chosen
based on its effects of elevating basal insulin release [3,4].
In addition, the fatty acid is associated with particularly β-
cell detrimental effects, where the underlying causes have
only partly been defined [4,6-10].
When episodes of hyperglycemia are not extended, granu-
lar exocytosis is balanced by formation of new insulin
granules resulting in maintained insulin content [21]. InProteome Science 2009, 7:24 http://www.proteomesci.com/content/7/1/24
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Table 1: Palmitate-regulated INS-1E proteins
Protein mass (kDa) pI Protein expression ratio (G20+PA)/G20
5.74 1.59
5.81 1.30
7.14 1.65
7.22 1.29
7.32 1.62
7.40 1.37
11.87 0.82
16.80 Calm1, Calm3 0.71
16.98 Calm1, Calm3 0.72
17.18 Calm1, Calm3 0.72
78.28 1.44
12 5.5 0.57
35 6.5 1.17
36 5.4 0.76
37 9.5 0.88
38 6.1 0.85
38 9.5 1.45
41 7.7 0.97
41 7.9 1.15
41 9.0 0.73
44 5.1 1.85
46 5.0 1.37
49 5.0 1.75
50 8.5 1.54
53 5.9 3.3
61 6.8 0.86
81 6.9 2.09
118 4.7 1.34
INS-1E cells were cultured at 20 mM glucose in the absence or presence of palmitate for 48 hours. After culture, cells were lysed and protein profiles obtained by SELDI-
TOF-MS using Q10-array or by 2D-PAGE. Masses of differentially expressed proteins by SELDI-TOF-MS (11 first proteins) or by 2D-PAGE are listed. Gene names of 
identified proteins are indicated. Results are means ± SEM 4–6 independent experiments.Proteome Science 2009, 7:24 http://www.proteomesci.com/content/7/1/24
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the present study, insulin content was severely reduced
after extended hyperglycemia similar to what was previ-
ously observed in INS-1E cells and primary islets [22,23].
In contrast, palmitate did not affect insulin content. De-
granulation has been suggested to be a main contributor
to the loss of GSIS. However, cells cultured in the presence
of 20 mM glucose and palmitate released similar amounts
of insulin in response to a stimulatory glucose concentra-
tion as control cells, despite reduced insulin content. We
concluded that other mechanism than lowered amounts
of insulin granules must also be operational in the aber-
rant insulin release observed from β-cells cultured at ele-
vated glucose alone or in combination with palmitate. To
address mechanisms responsible for the inability to main-
tain hormonal stores and to delineate other processes
contributing to the aberrant insulin release, glucose- and
palmitate-regulated β-cell proteins were identified by pro-
tein profiling.
Profiling was conducted with SELDI-TOF-MS and 2D-
PAGE to address how elevated levels of glucose and
palmitate affected the β-cell proteome. The combination
of the approaches was triggered by the preferential detec-
tion of proteins in the low molecular range by SELDI-
TOF-MS and high molecular range by 2D-PAGE [14,24].
Indeed, in the present study more than 80% of the peaks/
spots detected by SELDI-TOF-MS or 2D-PAGE were in the
4–20 kDa or 20–150 kDa range, respectively. Among
these peaks and spots differential expression was discov-
ered.
To elucidate mechanisms by which elevated levels of the
nutrients incur alterations in β-cell secretory function, the
identification of the differentially expressed proteins is
essential. Whereas such proteins are inherently separated
by 2D-PAGE and can be subjected to PMF, differentially
expressed proteins obtained by SELDI-TOF-MS need first
to be separated and enriched. The higher number of iden-
tified proteins derived from the 2D-PAGE approach
reflects this condition. On the other hand when changes
in complex protein patterns are studied and the identities
of the components are not demanded, SELDI-TOF-MS is
superior to 2D-PAGE [15]. In addition, the amount of
cells required to generate mass spectra and gels by the two
approaches, respectively, was about two orders of magni-
tude higher when utilizing 2D-PAGE. Although not a con-
sideration when profiling cell lines, the enhanced
sensitivity in SELDI-TOF-MS is crucial when analyzing
protein patterns of scarce tissue e.g. human islets [15].
In the present study, several proteins were differentially
expressed in response to elevated levels of glucose. The
up-regulation of glycolytic enzymes phosphoglycerate
kinase 1 and pyruvate kinase 3 together with enhanced
expression of NADH dehydrogenase flavoprotein 1 of
complex I of the respiratory chain indicate enhanced glu-
cose metabolism. Under such conditions formation of
reactive oxygen species (ROS) is enhanced [25]. It was
therefore not surprising that glucose-6-phosphate dehy-
drogenase was up-regulated. This enzyme is induced by
elevated ROS and determines production of nicotineam-
ide adenine dinucleotide phosphate hydrogen (NADPH)
via shuttling of glucose through the pentose phosphate
shunt. All major ROS-metabolic enzymes, directly or indi-
rectly depend on NADPH [26]. The glucose-induced pro-
teins glycyl-tRNA synthetase (gars) and heterogenous
nuclear ribonucleoprotein A3 (hnrnp A3) both serve reg-
ulatory functions in protein translation. Whereas gars cat-
alyzes the synthesis of glycyl-tRNA, which is required to
insert glycine into proteins [27], hnrnp A3 is involved in
Table 2: Glucose and palmitate-regulated INS-1E proteins
Gene name Protein name Synonyms Mr (Da) pI
Calm1, Calm3 Calmodulin 16696 4,09
G6pdx, G6pd Glucose-6-phosphate 1-dehydrogenase G6PD EC 1.1.1.49 59794 5,97
Ganab Alpha glucosidase 2 alpha neutral subunit 90857 5,77
Gars Gars protein 72669 5,76
Hnrnpa3, Hnrpa3 Heterogeneous nuclear ribonucleoprotein A3 hnRNP A3 37291 8,46
Lonp1, Lon, Prss15 Lon peptidase 1 EC 3.4.21.-, Lon protease-like protein LONP, 
Mitochondrial ATP-dependent protease Lon, 
Serine protease 15
106296 6,17
Ndufv1 NADH dehydrogenase (ubiquinone) flavoprotein 1 51383 8,37
Pgk1, Pgk-1 Phosphoglycerate kinase 1 EC 2.7.2.3 44909 8,02
Psmc5 Proteasome p45/SUG 42174 7,11
Rab2 RAB2, member RAS oncogene family 18513 6,43
RGD1561681_predict. Pyruvate kinase 3 58312 7,15
Tcp1, Cct1, Ccta t-complex protein 1 CCT-alpha, TCP-1-alpha 60835 5,86
INS-1E cells were cultured at 5.5 or 20 mM glucose in the absence or presence of palmitate for 48 hours. After culture, cells were lysed and protein 
profiled. Differentially expressed proteins by glucose or palmitate were identified by peptide mass fingerprinting. Mr and pI denote relative 
molecular mass and isoelectric point of the protein.Proteome Science 2009, 7:24 http://www.proteomesci.com/content/7/1/24
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pre-mRNA processing, transcriptional regulation, recom-
bination and telomere maintenance [28]. Further effects
on protein synthesis were indicated by the up-regulated
endoplasmic reticulum (ER)-associated alpha glucosidase
2 and cytoplasmic t-complex protein 1. Both proteins take
part in protein folding where the former enzyme is an
important part of the calnexin/calreticulin protein synthe-
sis quality control system [29] and the latter acts as a chap-
erone with folding capacity [30]. The importance of
glucose-induced ROS and its negative effects on proteins
was also indicated by up-regulation of the lon protein,
which is a mitochondrial ATP-dependent protease
engaged in mitochondrial protein degradation by recog-
nizing unfolded proteins [31,32].
However, proteasomal degradation may also be enhanced
as indicated by the rise in proteasome p45. In this context
accumulation of insulin and other granular proteins in
the ER may play a role as indicated by the glucose-induced
up-regulation of rab2. This small GTPase decreases vesic-
ular transport between the ER and the Golgi complex
when induced [33]. Indeed, glucose-induced rab2 with
ensuing impaired anterograde transport of secretory gran-
ule protein precursors may contribute to explain the
observed decrease in GSIS and insulin content. The latter
findings are in contrast to when islets were exposed to ele-
vated glucose levels for a shorter time period [14]. When
such islets were protein profiled manifestations of
enhanced granular formation maturation and trafficking
were obtained. The lowered hormonal levels obtained in
cells exposed to prolonged elevated glucose levels indicate
that protein degradation is surpassing synthesis, where
the latter may even be attenuated. Such cellular reactions
are observed as manifestations of the unfolded protein
response (UPR), which is a cellular adaptive response sys-
tems initiated when the protein synthesis machinery is
compromised [34]. Indeed, initiation of the UPR has been
observed in β-cells exposed to prolonged elevated glucose
levels [35]. In such cells, induction of lipogenic enzymes
resulting in lipid accumulation was proposed to explain
the impaired GSIS. When the lipogenic expression was
decreased, GSIS was improved. The improvement of the
stimulatory secretory levels in the present study when
including the fatty acid palmitate during the acute expo-
sure may therefore be explained by maintaining fatty acid
cellular levels, which are critical for optimal GSIS [36].
Increased basal insulin release was observed when cells
were cultured in the presence of palmitate, confirming
previous studies in INS-1E cells [4,12,37] and isolated
islets [3]. Several β-cell proteins were regulated by palmi-
tate. One of these proteins was identified as calmodulin.
This protein is likely to undergo post-translational modi-
fications such as phosphorylation [38], which may
account for the three separate peaks observed. Calmodu-
lin in INS-1E cells was lowered when palmitate was added
to culture medium containing 20 mM glucose. Its role in
insulin secretion is pleiotropic including regulation of the
cytoplasmic Ca2+  concentration by controlling Ca2+-
ATPases of the plasma membrane and the ER [39,40],
which has effects on mobilization and exocytosis of insu-
lin granules [41,42]. In addition, calmodulin is regulating
kinase and phospahatase activities via Ca2+/calmodulin-
dependent protein kinases and calcineurin, respectively
[43,44]. In a previous study, we observed that palmitate-
induced rise in basal insulin secretion was counteracted in
INS-1E cells over-expressing CPT1 in a regulated manner
[12]. The role of calmodulin for this partial normalization
of basal insulin release appears to be minimal since cal-
modulin levels were not affected by over-expressing the
fatty acid transporter. Instead, over-expression of CPT1
normalized a 7.14 kDa protein, which was highly elevated
in cells exposed to augmented levels of palmitate or glu-
cose. The beneficial effects of CPT1 over-expression was
accompanied by alleviation of apoptosis and attenuation
of UPR-markers phosphorylated eIF2α and pro-apoptotic
Table 3: Glucose and palmitate-regulated INS-1E proteins
Gene name Primary accession no. Ncbi accession no. No. peptides matched Seq cov (%) Mowse score
Calm1, Calm3 P62161 NP_114175.1
NP_036650.1
44 2 9 0
G6pdx, G6pd P05370 NP_058702 29 40 176
Ganab NP_001099804 19 25 191
Gars Q5I0G4 AAH88347 19 40 155
Hnrnpa3, Hnrpa3 Q6URK4 NP_444493 23 105
Lonp1, Lon, Prss15 Q924S5 NP_596895 15 18 143
Ndufv1 Q5XIH3 NP_001006973 17 37 194
Pgk1, Pgk-1 P16617 NP_445743 15 52 131
Psmc5 O35050 BAA22935 17 41 190
Rab2 P05712 EDM11646 9 55 108
RGD1561681_predict. XP_001054125 27 58 257
Tcp1, Cct1, Ccta P28480 NP_036802 18 34 146
INS-1E cells were cultured at 5.5 or 20 mM glucose in the absence or presence of palmitate for 48 hours. After culture, cells were lysed and protein 
profiled. Differentially expressed proteins by glucose or palmitate were identified by peptide mass fingerprinting.Proteome Science 2009, 7:24 http://www.proteomesci.com/content/7/1/24
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CHOP/GADD153 [12]. Factors contributing to elevated
basal insulin secretion and palmitate-induced alterations
in GSIS have instead been attributed to altered expression
of enzymes of glucose metabolism including glucokinase,
phosphofructokinase and pyruvate dehydrogenase, and
of the fatty acid receptor GPR40 [45-47].
Conclusion
In conclusion, differentially expressed proteins were iden-
tified by protein profiling of insulin-producing β-cells
exposed to prolonged elevated glucose and palmitate lev-
els. The identified proteins may represent mechanisms
involved in islet functional deterioration in T2DM.
Methods
Chemicals and reagents
Reagents of analytical grade and MilliQ water were used.
Glucose, HEPES, insulin peroxidase, DTT, CHAPS, Triz-
maBase, sinapinic acid, sodium pyruvate, glutamine, pen-
icillin, streptomycin, sodium salt of palmitate and
doxycycline were obtained from Sigma (St. Lous, MO).
BSA fraction V (fatty acid free) was purchased from Boe-
hringer Mannheim GmbH (Mannheim, Germany). Urea,
2-D Quant Kit and Pharmalyte 3 to 10 were purchased
from GE Healthcare (Uppsala, Sweden) and ASB14 from
Calbiochem (San Diego, CA). Alpha-cyano-4-hydroxy-
cinnamic acid (CHCA), immobilised pH gradient (IPG)
Ready Strips (11 cm), peptide/protein molecular weight
standards, pH range 3–10 non-linear, ReadyPrep 2-D
Cleanup Kit, 2-D SDS-PAGE Standards and 12.5% precast
polyacrylamide gels (Criterion Gel System) were pur-
chased from Bio-Rad (Hercules, CA). PEFA-bloc®, ace-
tonitrile, formic acid, trifluoroacetic acid and octyl-β-D-
Glucopyranoside, thiourea, Triton X-100, ammonium
hydroxide, citric acid monohydrate, glacial acetic acid,
methanol and Tris were purchased from Merck (Darm-
stadt, Germany). Trypsin was obtained from Roche Diag-
nostics (Indianapolis, IN). RPMI 1640 culture medium,
fetal bovine serum (FBS), sodium pyruvate, glutamine,
penicillin, streptomycin were purchased from Invitrogen
(Carlsbad, CA). Culture flasks and culture plates were
obtained from BD Biosciences Labware (Franklin Lakes,
NJ). PageBlue protein staining solution and prestained
protein ladder were purchased from Fermentas (Vilnius,
Lithuania). The rat insulin standard was obtained from
Novo Nordisk (Bagsvaerd, Denmark). Guinea pig anti-
mouse insulin antibodies were produced in our labora-
tory. IgG certified 96-well microtiter plates were pur-
chased from Nunc (Roskilde, Denmark).
Cell culture
Rat insulinoma INS-1E cells, kindly donated by Dr. Pierre
Maechler, Geneva University [48], were cultured between
passages 76–90 in a humidified atmosphere containing
5% CO2 in RPMI 1640 medium supplemented with 10
mM HEPES, 10% (v/v) heat-inactivated FCS, 2 mM
glutamine, 100 U/ml penicillin, 100 μg/ml streptomycin,
1 mM sodium pyruvate and 50 μM β-mercaptoethanol.
Cells were exposed to 5.5 or 20 mM glucose in the absence
of presence of 0.5 mM palmitate for 48 hours. Fatty acid
stock solution of palmitate (100 mM) was prepared in
50% ethanol. This stock solution was diluted in the cul-
ture medium to a final concentration of 0.5 mM and then
allowed to complex with 0.5% fatty acid-free BSA. The
CPT-1 over-expression was performed with a regulated
adenoviral construct as previously described [12].
INS-1E cell SELDI-TOF mass spectra and 2D-PAGE map Figure 2
INS-1E cell SELDI-TOF mass spectra and 2D-PAGE 
map. SELDI-TOF mass spectrum (A) and 2D-PAGE map (B) 
generated from INS-1E cells cultured at 20 mM glucose in 
the absence or presence of 0.5 mM palmitate for 48 hours. 
Representative mass spectrum with magnified area of cal-
modulin with the tentative masses of 16.8, 17.0 and 17.2 kDa, 
(n = 6) from cells cultured at 20 mM glucose alone (black 
traces) or presence of palmitate (red traces). Identified pro-
teins are marked in the gel image by their gene names. Mr, m/
z and pI denote relative molecular mass, mass over charge 
and isoelectric point of the protein.Proteome Science 2009, 7:24 http://www.proteomesci.com/content/7/1/24
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Measurements of insulin secretion and insulin content
After culture, GSIS was measured from INS-1E cells as pre-
viously described [12]. The cells were maintained for 1
hour at 37°C in culture medium containing 3 mM glucose
in the presence or absence of palmitate followed by
another 1 hour incubation in buffer containing 0.5% fatty
acid free BSA and (in mM): NaCl 125, KCl 5.9, MgCl2 1.2,
CaCl2 1.28, HEPES 25, glucose 3 and palmitate 0 or 0.5
titrated to pH 7.4 with NaOH. GSIS was measured from
INS-1E cells incubated for 30 min at 37°C in similarly
composed buffer with either 3 or 20 mM glucose in the
absence or presence of palmitate, respectively. After incu-
bation, supernatants were collected and stored at -20°C
until assayed by enzyme-linked immuno-sorbent assay
(ELISA) [49]. INS-1E cells were subsequently washed in a
similar buffer as used for insulin release experiments with-
out BSA, lysed in 0.1% Triton X-100 and 25 mM NaOH
and stored at -20°C until assayed for total protein or insu-
lin content measurements by DC protein assay (BioRad)
and ELISA [49], respectively. Insulin release and content
were normalized to total protein.
Normalized expression of the 7.14 kDa protein in INS-1E  cells by CPT1 over-expressing Figure 3
Normalized expression of the 7.14 kDa protein in 
INS-1E cells by CPT1 over-expressing. The 7.14 kDa 
protein was elevated in INS-1E cells cultured in the presence 
of 20 mM glucose and 0.5 mM palmitate. Enhanced CPT1-
expression induced by 0.2 or 1 μM doxycycline, normalized 
the levels of the 7.14 kDa protein. Results are means ± SEM 
for six independent experiments. *P < 0.05 compared to 
cells cultured at 20 mM glucose, #p < 0.05 compared to non-
induced INS-1E cells cultured in the presence of 20 mM glu-
cose and palmitate.
Table 4: Glucose-regulated INS-1E proteins
Protein mass (kDa) pI Protein expression ratio G20/G5.5
5.74 0.63
5.81 0.70
7.22 0.79
11.87 1.21
40.19 1.36
26 Rab2 5.9 1.7
28 7.6 3.51
35 7.9 34.8
38 6.0 1.25
39 8.7 1.29
40 Hnrnpa3, Hnrpa3 8.6 1.24
41 5.1 2.07
41 5.9 1.16
43 Pgk1, Pgk-1 8.2 1.57
45 Psma6 7.5 1.43
50 4.5 55.9
51Ndufv1 7.9 1.18
55 6.0 1.26
57 6.3 2.52
58 G6pdx, G6pd 5.9 1.69
59 RGD1561681_predict. 7.8 1.75
61 Tcp1, Cct1, Ccta 5.8 1.53
61 5.8 1.79
63 5.0 1.51
63 5.8 1.16
65 6.0 1.31Proteome Science 2009, 7:24 http://www.proteomesci.com/content/7/1/24
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Sample preparation and protein profiling
SELDI
INS-1E cells samples were prepared and protein profiled
essentially as described previously [13]. The cells lysed in
buffer consisting of 50 mM Trizmabase, 8 M Urea, 3%
CHAPS, 1% ASB14 and 5 mM PEFA-bloc and diluted
three times with 50 mM Trizmabase. Total protein con-
tent was determined with Lowry assay (BioRad, Hercules,
CA) and the samples were stored at -80°C until analysis.
Protein arrays with a chromatographic surface of anionic
exchanger, Q10 (Bio-Rad), were used for profiling. Sam-
ples were diluted in binding buffer consisting of 0.1 M
phosphate buffer, pH 7.0, supplemented with 0.1% Tri-
ton X-100 to a protein concentration of 0.1 μg/μl and
applied on the protein arrays. Arrays with sample and
peptide/protein molecular weight standards were read in
a PBSII (Bio-Rad). Generated mass spectrograms were
analyzed using the supplied software (Bio-Rad).
Two-dimensional gel electrophoresis
Samples were prepared and protein profiled essentially as
described previously [14]. INS-1E cells were lysed in
buffer containing 1% Triton X-100, 1% SDS and protease
inhibitor cocktail, homogenized by sonication, which was
followed by treatment with ReadyPrep 2-D cleanup Kit.
The protein pellet was re-suspended in rehydration solu-
tion containing 7 M urea, 2 M thiourea, 0.5% Triton X-
100, 4% CHAPS, 0.5% pharmalyte (pH 3–10), 0.1% NP-
7 and 60 mM DTT for the iso-electric focusing (IEF) and
protein concentration was determined using a 2-D Quant
Kit. The protein amount per gel was 250 μg.
Individual 11-cm IPG strips, pH 3–10 NL, were rehy-
drated in 185 μl of sample at 20°C for 15 hours. The rehy-
drated strips were then focused on the Protean IEF Cell
(Bio-Rad) for about 35 kV·h at a maximum of 8.0 kV in
rapid voltage ramping mode with a maximum current per
strip of 50 μA. The equilibration of the IPG strips after IEF
was performed by reduction in a solution containing 1%
DTT, 6 M urea, 2% SDS, 30% glycerol, 0.002% Coomassie
Brilliant Blue R-250 (CBB) and 0.05 M Tris pH 8.8 fol-
lowed by alkylation in a solution containing 6 M Urea,
2% SDS, 30% glycerol, 0.002% CBB, 0.05 M Tris pH 8.8
and 4% iodoacetamide.
Protein mass separation was performed by electrophoresis
using 12.5% precast SDS-polyacrylamide gels, which were
stained with Pageblue protein staining solution overnight
and imaged using a GS-800-calibrated densitometer (Bio-
Rad). Raw scans were processed quantitatively, qualita-
tively and statistically analyzed by the 2-D gel analysis
software, PDQuest (Bio-Rad). For between-gel compari-
sons, a set of spot generation conditions was used. The
quantity of each spot was normalized by the total inten-
sity of valid spots to minimize the effect of experimental
factors on protein spots. All the quantitatively different
spots were also verified manually.
Protein purification and identification
The identities of differentially expressed proteins discov-
ered by SELDI-TOF-MS or 2D-PAGE were obtained by
peptide mass fingerprinting (PMF) essentially as
described previously [14,18]. Proteins discovered by
SELD-TOF MS had to be purified by anion exchange
(Vivapure Q Mini spin columns, Vivascience, Hannover,
Germany) and hydrophobic fractionation (Polymer Lab-
oratories, Darmstadt, Germany), separated by 18% SDS-
PAGE and stained in colloidal Coomassie stainer over
night prior to PMF. Purified and separated proteins were
verified to correspond with the SELDI-TOF-MS discovered
proteins by applying passively eluted proteins from the
gel pieces on NP20-chip. Gel pieces containing relevant
proteins, discovered by either SELDI-TOF-MS or 2D-
PAGE, were in-gel digested followed by mass determina-
tion of the tryptic fragments recorded on an Applied Bio-
systems Q-STAR XL with a ProteinChip Interface (PCI-
1000) Q-star MALDI-TOF mass spectrometer for proteins
discovered by SEDLI-TOF MS or a Bruker Reflex IV (Bruker
Daltonics, Bremen, Germany) MALDI-TOF mass spec-
trometer for proteins discovered by 2D-PAGE. All mass
spectra were internally calibrated with trypsin autolysis
products and masses of known contaminants e.g. keratin
were removed. Proteins were identified by PMF with the
search program Mascot (Matrix Science, London, UK).
The criteria used to accept identifications included the
molecular weight search (MOWSE) score (protein scores
greater than 61 was considered significant) and whether
the theoretical molecular weight ± 20% and pI  of the
69 5.9 1.27
71 6.0 1.80
72 Gars 5.8 2.15
73 5.7 1.42
81 5.5 1.27
89 Ganab 5.6 1.46
90 Ganab 5.6 1.37
93 Lonp1, Lon, Prss15 5.8 1.86
INS-1E cells were cultured at 5.5 or 20 mM glucose for 48 hours. 
After culture, cells were lysed and protein profiles generated by 
SELDI-TOF-MS using Q10-array or by 2D-PAGE. Masses of 
differentially expressed proteins obtained by SELDI-TOF-MS (5 first 
proteins) or by 2D-PAGE are listed. Gene names of identified 
proteins are indicated. Results are means ± SEM 4–6 independent 
experiments.
Table 4: Glucose-regulated INS-1E proteins (Continued)Proteome Science 2009, 7:24 http://www.proteomesci.com/content/7/1/24
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matched protein were within the experimental pI value ±
1.00. SWISS-PROT was used as the protein sequence data-
base and the peptide masses were compared to the theo-
retical peptide masses of all available proteins from Rattus
norvegicus. Information about the identified protein and
its putative function was found at the ExPASy Molecular
Biology Server at SWISS-PROT http://www.expasy.org and
at the National Centre for Biotechnology Information
(NCBI), which were accessed between June–July 2008.
Statistical analysis
The insulin release data are represented as means ± SEM
for four to six independent experiments. Differences
between groups are assessed by one-way ANOVA followed
by Tukey's post hoc test. Probability level of p < 0.05 was
considered to be statistically significant. Significant
changes between the protein profiles for four to seven
independent experiments were determined using Stu-
dent's t-test.
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